IE822952L - Macrocyclic compounds - Google Patents

Macrocyclic compounds

Info

Publication number
IE822952L
IE822952L IE822952A IE295282A IE822952L IE 822952 L IE822952 L IE 822952L IE 822952 A IE822952 A IE 822952A IE 295282 A IE295282 A IE 295282A IE 822952 L IE822952 L IE 822952L
Authority
IE
Ireland
Prior art keywords
hydrogen
optionally substituted
ring system
alkyl
halo
Prior art date
Application number
IE822952A
Other versions
IE54283B1 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IE822952L publication Critical patent/IE822952L/en
Publication of IE54283B1 publication Critical patent/IE54283B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ester derivatives of 5-O-mycaminosyl tylonolide (OMT) of the formula <IMAGE> wherein R and R1 are selected from hydrogen, optionally substituted C1-C5-alkanoyl or optionally substituted benzoyl, phenylacetyl, or phenylpropionyl; R2 is hydrogen or an acyl group selected from: <IMAGE> +TR <IMAGE> p is 0 or 1; m and n are integers from 0 to 4; R3 is hydrogen, halo, C1-C4-alkyl, C3-C8-cycloalkyl, phenyl, C5-C8-cycloalkenyl, naphthyl, indenyl, tetralinyl, decalinyl, adamantyl, cinnoxacinyl, a monocyclic heterocyclic ring system comprising 3 to 8 atoms in the ring or a bicyclic heterocylic ring system comprising 6 to 11 atoms, provided that at least 1 atom of the ring system is carbon and at least 1 atom of the ring system is a heteroatom selected from O, N, and S; and wherein R3 and the connecting alkyl groups-(CH2)m- and -(CH2)n- are optionally substituted by one or two halo, methyl, ethyl, methoxy, amino, N-protected-amino, methylamino, dimethylamino, nitro, acetoxy, acetamido, azido, carbomethoxy, carboxamido, cyano, or hydroxyl groups, provided that, if the substituent is other than halo or alkyl, there can be no more than one substituent on any connecting -CH2- group; X is O, S, -NH-, -N(CH3)-, -C 3BOND C-, -CH=CH-, -C(CH3)=CH-, -CH=C(CH3)- or -C(CH3)=C (CH3)-; R4 and R5 are C1-C5-alkyl or optionally substituted phenyl or benzyl; provided that at least one of R, R1 and R2 must be other than hydrogen and that, when R1 is other than hydrogen, R must also be other than hydrogen; and salts thereof; which are useful antibiotics or intermediates to antibiotics, are provided. [US4401660A]
IE2952/82A 1981-12-14 1982-12-13 Omt ester derivatives IE54283B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/330,341 US4401660A (en) 1981-12-14 1981-12-14 Ester derivatives of 5-O-mycaminosyl tylonolide and method of using same

Publications (2)

Publication Number Publication Date
IE822952L true IE822952L (en) 1983-06-14
IE54283B1 IE54283B1 (en) 1989-08-16

Family

ID=23289335

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2952/82A IE54283B1 (en) 1981-12-14 1982-12-13 Omt ester derivatives

Country Status (12)

Country Link
US (1) US4401660A (en)
EP (1) EP0082003B1 (en)
JP (1) JPS58110598A (en)
KR (1) KR850000978B1 (en)
CA (1) CA1189503A (en)
DE (1) DE3268461D1 (en)
DK (2) DK153794C (en)
GB (1) GB2111497B (en)
GR (1) GR77094B (en)
HU (1) HU194268B (en)
IE (1) IE54283B1 (en)
IL (1) IL67452A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU551142B2 (en) * 1981-07-09 1986-04-17 Zaidan Hojin Biseibutsu Kagaku Kenkyukai Tylosin derivatives
CA1196915A (en) * 1982-01-22 1985-11-19 Hideo Sakakibara 23-0-acyl-23-demycinosyldesmycosin
US4443436A (en) 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
US4629786A (en) * 1983-02-28 1986-12-16 Eli Lilly And Company C-20- and C-23 modified macrolide derivatives
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
US4576931A (en) * 1985-04-03 1986-03-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai (Microbial Chemistry Research Foundation) 23-C-Substituted mycaminosyl tylonolide, pharmaceutical compositions and method of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE667952A (en) * 1964-08-05
US4092473A (en) * 1975-08-01 1978-05-30 Sanraku Ocean Co., Ltd. Tylosin derivatives and their manufacturing process
US4321362A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company De(mycinosyloxy)tylosin and process for its production
US4438109A (en) * 1980-07-25 1984-03-20 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Tylosin derivatives
US4299953A (en) * 1980-07-29 1981-11-10 Eli Lilly And Company Mycarosyltylactone

Also Published As

Publication number Publication date
GB2111497A (en) 1983-07-06
DK153794B (en) 1988-09-05
KR840002855A (en) 1984-07-21
GR77094B (en) 1984-09-06
EP0082003A1 (en) 1983-06-22
DE3268461D1 (en) 1986-02-20
DK623786D0 (en) 1986-12-22
EP0082003B1 (en) 1986-01-08
CA1189503A (en) 1985-06-25
HU194268B (en) 1988-01-28
IL67452A0 (en) 1983-05-15
DK553982A (en) 1983-06-15
DK153794C (en) 1989-02-20
JPS58110598A (en) 1983-07-01
DK623786A (en) 1986-12-22
KR850000978B1 (en) 1985-07-05
GB2111497B (en) 1985-10-30
US4401660A (en) 1983-08-30
IL67452A (en) 1985-12-31
IE54283B1 (en) 1989-08-16

Similar Documents

Publication Publication Date Title
FI894364A0 (en) STEROIDER MED EN 19,11B, BRYGGA, FRAMSTAELLNING AV OCH PHARMACEUTICAL COMPOSITION INNEHAOLLANDE DESAMMA.
IE780899L (en) Azetidinopyrrole derivatives
AU1178588A (en) New 19-norsteroids substituted at the 7-position, their preparation, their application as drugs and the pharmaceutical compositions containing them
CA2092330A1 (en) Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
IE822952L (en) Macrocyclic compounds
IE800669L (en) Cephalosporins.
KR850003409A (en) Method for preparing N-acyl glycopeptide derivative
IE791339L (en) Derivatives of 19-nor-3,20-diketosteroids
NO944069L (en) Inhibition of uterine fibrosis
ES8705891A1 (en) Cephalosporin antibiotics
JPS57112396A (en) Novel cephem compound, its preparation and prophylactic or remedy for microbism
ES8506731A1 (en) Cephalosporin derivatives.
Traxler et al. Synthesis of N-acetyldeacetoxy-cephalosporin C by a mutant of Cephalosporium acremonium
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
DK532282A (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORIN DERIVATIVES SUBSTITUTED WITH A THIOMETHYL-HETEROCYCLIC GROUP IN THE 3-POSITION
JPS5246093A (en) 2-alkyl-7-substituted-2, or 3-cephem-4-carboxylic compounds, their sal ts, and preparation thereof
DE68919433D1 (en) Cephalosporins, processes for their preparation, intermediates and pharmaceutical preparations.
JPS52100484A (en) Synthesis of antibiotic derivatives
JPS56152479A (en) Optically active cephalosporin analog
JPS55164671A (en) Azetidine derivative and its preparation
ES2038997T3 (en) PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF CEPHALOSPORINS.
ES2133567T3 (en) DERIVATIVES OF ERYTHROMYCIN.
IE43686L (en) Oxadiazole derivatives
JPS56118084A (en) Optically active cephalosporin analogue
JPS5746967A (en) Novel mandelic 3-hydroxy-1,2-diazine-6-yl-thiol ester and its preparation